缺乏-eIF4E会通过抑制Treg抑制活性使实验性结肠炎恶化
François Santinon1,2, Theodoros Papadopoulos3,4, Meagan-Helen Henderson Berg3,4,5
1Division of Clinical and Translational Research, McGill University, Montreal, Québec, Canada. francoissantinon@gmail.com.
Journal of inflammation (London, England)
|November 6, 2025
概括
-eIF4E对于调节T细胞 (Treg) 功能和控制炎症至关重要. 其缺乏会损害Treg活性,导致结肠炎恶化和免疫抑制降低.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 该MNK1/2-eIF4E通路调节蛋白质合成和免疫细胞基因表达.
- 这个轴的失调与疾病有关,但它在CD4+T细胞子集,特别是调节性T细胞 (Tregs) 中的作用尚不清楚.
- 这项研究调查了-eIF4E缺乏对Treg功能在炎症条件的影响.
研究的目的:
- 阐明-eIF4E在调控T细胞 (Treg) 生物学中的作用.
- 为了确定-eIF4E缺乏对Treg介导的免疫抑制的影响.
- 研究-eIF4E对实验性结肠炎和人类外周血液单核细胞 (PBMC) 的影响.
主要方法:
- 研究了患有-eIF4E缺乏Tregs (S209A突变) 的小鼠.
- 使用了大肠炎的小鼠模型.
- 分析了人类外周血液单核细胞 (PBMC) 和免疫细胞群 (CD4+ T细胞,Tregs,IFNγ表达细胞).
主要成果:
- 缺乏-eIF4E的Tregs在体外表现出抑制CD4+T细胞增殖和IFNγ分泌的能力降低.
- 缺乏-eIF4E的小鼠表现出恶化的结肠炎,IFNγ+ CD4+ T细胞增加和Tregs减少.
- 缺乏-eIF4E的T细胞显示Treg分化受损,缺乏Tregs减少了FoxP3表达和淋巴结迁移受损.
- 抗CTLA-4疗法,但不是抗PD-1,在人类PBMC中减少了表达-eIF4E的Tregs.
结论:
- -eIF4E在调节T细胞 (Treg) 功能中起着重要作用.
- -eIF4E通路对于控制炎症至关重要.
- 向-eIF4E可能在炎症性疾病中提供治疗潜力.
更多相关视频
07:34Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
3.1K
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
12.7K
相关概念视频
01:22Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.6K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.6K
01:29Inflammatory Bowel Disease IV: Pharmacological Management
459
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
459